The main objective of this study is to establish the postoperative "pain pathways" observed from D1 to D7 in the context of the current management after orthopedic, digestive, obstetrics and gynecology, urology, neurosurgery, vascular and thoracicn surgeries.
The secondary objectives of this study are: A. To assess the incidence of Post-Surgical Chronic Pain (PSCP) Chronic 3 months post intervention. B. To asses the incidence of neuropathic type pain (DN4 Questionnaire) at 3 months post intervention. C. To study the potential links between pain trajectories and the presence or absence of PSCP. D. To study the potential links between the presence or absence of PSCP and known risk factors for PSCP (patient-related data, data on the surgery, anesthesia data).
Study Type
OBSERVATIONAL
Enrollment
392
Patients will be contacted at 3 months post-surgery for pain questionnaires.
Patients will evaluate their pain levels via a verbal numerical scale on days 1(or-1), 2, 3, 4, 5, 6 \& 7.
Patients are required to fill out the HADS and PCS questionnaires between on day -1 or +1.
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France
The pain trajectory for the first 7 post-operative days.
The pain trajectory is the vector of 7 verbal numerical pain estimates (from 0 to 10) taken over 7 days (days 1 (or -1), 2, 3, 4, 5, 6 \& 7). Day 0 is the day of surgery.
Time frame: Day 7 post-surgery
The DN4 questionnaire
Time frame: month 3
Since the surgery, do you have persistent pain? yes/no
Time frame: month 3
Is it the same pain before the surgery? yes/no
Time frame: month 3
Verbal numberical scale for pain (ranging from 0 to 10)
Time frame: month 3
Have you had complications from your surgery? yes/no
Time frame: month 3
Hospital Anxiety and Depression Scale (HADS)
Time frame: day -1 or day +1
Pain Catastrophizing Scale (PCS)
Time frame: day -1 or day +1
Cumulative consumption of antalgic drugs
Time frame: day -1 or day +1
Cumulative consumption of antalgic drugs
Time frame: day 2
Cumulative consumption of antalgic drugs
Time frame: day 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cumulative consumption of antalgic drugs
Time frame: day 4
Cumulative consumption of antalgic drugs
Time frame: day 5
Cumulative consumption of antalgic drugs
Time frame: day 6
Cumulative consumption of antalgic drugs
Time frame: day 7